These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1534209)

  • 41. Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile.
    Hirata H; Ogawa N; Asanuma M; Ota Z; Mori A
    Brain Res; 1993 Feb; 604(1-2):197-204. PubMed ID: 8457848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T; Tanji H; Kato H; Itoyama Y
    J Neurol Sci; 1998 Oct; 160(2):121-7. PubMed ID: 9849794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity.
    Nikolaus S; Wittsack HJ; Beu M; Antke C; Hautzel H; Wickrath F; Müller-Lutz A; De Souza Silva MA; Huston JP; Antoch G; Müller HW
    Pharmacol Biochem Behav; 2019 Apr; 179():156-170. PubMed ID: 30639878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavioral characterization of intracranial self-stimulation from mesolimbic, mesocortical, nigrostriatal, hypothalamic and extra-hypothalamic sites in the non-inbred CD-1 mouse strain.
    Zacharko RM; Kasian M; Irwin J; Zalcman S; LaLonde G; MacNeil G; Anisman H
    Behav Brain Res; 1990 Jan; 36(3):251-81. PubMed ID: 2310489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.
    Csernansky JG; Glick S; Mellentin J
    Psychopharmacology (Berl); 1987; 91(4):440-4. PubMed ID: 3108924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
    Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T
    Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.
    Dubois A; Savasta M; Curet O; Scatton B
    Neuroscience; 1986 Sep; 19(1):125-37. PubMed ID: 2946980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethanol administration does not alter dopamine D1 and D2 receptor characteristics in rat brain.
    Hietala J; Salonen I; Lappalainen J; Syvälahti E
    Neurosci Lett; 1990 Jan; 108(3):289-94. PubMed ID: 2137566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of chronic nicotine administration on dopaminergic receptor binding sites in rat nigrostriatal and mesolimbic regions.
    Fung YK; Lau YS
    Gen Pharmacol; 1991; 22(1):117-9. PubMed ID: 2050279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The modulation of brain dopamine and GABAA receptors by estradiol: a clue for CNS changes occurring at menopause.
    Bossé R; DiPaolo T
    Cell Mol Neurobiol; 1996 Apr; 16(2):199-212. PubMed ID: 8743969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics.
    Joyce JN; Gurevich EV
    Ann N Y Acad Sci; 1999 Jun; 877():595-613. PubMed ID: 10415673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system.
    Andersson JL; Marcus M; Nomikos GG; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):236-43. PubMed ID: 7911558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
    Han M; Huang XF; Deng C
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amphetamine-induced rotation reveals post 6-OHDA lesion neurochemical reorganization.
    Lynch MR; Carey RJ
    Behav Brain Res; 1989 Feb; 32(1):69-74. PubMed ID: 2495013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M; Sjöholm B; Lappalainen J; Virtanen R
    Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia.
    Mayfield RD; Jones BA; Miller HA; Simosky JK; Larson GA; Zahniser NR
    Synapse; 1999 Sep; 33(4):274-81. PubMed ID: 10421708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
    Deutch AY; Tam SY; Freeman AS; Bowers MB; Roth RH
    Eur J Pharmacol; 1987 Feb; 134(3):257-64. PubMed ID: 3569414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neuron system of human brain.
    De Keyser J; De Backer JP; Ebinger G; Vauquelin G
    J Neurol Sci; 1985 Nov; 71(1):119-27. PubMed ID: 2935593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.